Home โบ Macular Edema
Macular Edema clinical trials recruiting in the U.S.
8 studies for Macular Edema are recruiting participants at sites across the United States.
Cities with the most studies
- Hagerstown, MD4 studies
- Austin, TX4 studies
- Eugene, OR3 studies
- Carmel, IN3 studies
- Pasadena, CA3 studies
- Cleveland, OH3 studies
- The Woodlands, TX3 studies
- Raleigh, NC3 studies
- Phoenix, AZ3 studies
- Nashville, TN3 studies
- Fort Lauderdale, FL3 studies
- San Antonio, TX3 studies
- Boston, MA3 studies
- Houston, TX3 studies
- Denver, CO3 studies
- Charleston, SC3 studies
- Columbia, SC3 studies
- Glendale, CA3 studies
By state
- Arizona3 studies
- California4 studies
- Colorado4 studies
- Connecticut3 studies
- Florida4 studies
- Indiana3 studies
- Maryland4 studies
- Massachusetts3 studies
- New Jersey3 studies
- New York3 studies
- North Carolina5 studies
- Ohio3 studies
- Oregon3 studies
- Pennsylvania3 studies
- South Carolina5 studies
- Tennessee4 studies
- Texas4 studies
Recently updated studies
A Clinical Trial of MK-8748 Compared to Aflibercept in Participants With Diabetic Macular Edema (MK-8748-004)
RecruitingPhase 3
Ages 18 and older ยท All sexes ยท Updated Sep 28, 2026 ยท NCT07705555A Clinical Trial of MK-8748 Compared to Aflibercept in Participants With Diabetic Macular Edema (MK-8748-005)
RecruitingPhase 3
Ages 18 and older ยท All sexes ยท Updated Sep 28, 2026 ยท NCT07705607A Study to Test Whether BI 1815368 Helps People With an Eye Condition Called Diabetic Macular Edema
RecruitingPhase 2
Ages 18 and older ยท All sexes ยท Updated Sep 22, 2026 ยท NCT06962839Evaluating the Safety and Tolerability of Orally Administered DF-003 in ROSAH Syndrome Patients
RecruitingPhase 1
Ages 18 to 65 ยท All sexes ยท Updated Jun 5, 2026 ยท NCT06395285A Phase 3 Study to Evaluate the Efficacy and Safety of Intravitreal KSI-101 in Participants With Macular Edema Secondary to Inflammation (MESI) - PINNACLE
RecruitingPhase 3
Ages 18 and older ยท All sexes ยท Updated May 18, 2026 ยท NCT06996080A Phase 3 Study to Evaluate the Efficacy and Safety of Intravitreal KSI-101 in Participants With Macular Edema Secondary to Inflammation (MESI) - PEAK
RecruitingPhase 3
Ages 18 and older ยท All sexes ยท Updated May 18, 2026 ยท NCT06990399Therapeutic Contact Lens Drug Delivery System (TCL-DDS) in Patients With Recurrent Cystoid Macular Edema
RecruitingPhase 1/2
Ages 18 to 85 ยท All sexes ยท Updated Nov 26, 2025 ยท NCT04225611Imaging Retinal Vasculature in Infant Eyes
RecruitingObservational study
2 Months ยท All sexes ยท Updated Oct 6, 2025 ยท NCT05558059From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.